Bayer’s AI in New Biological Gets Approval in Europe
Bayer CropScience said that Terpenoid Blend QRD 460, the active ingredient of its biological insecticide Requiem which is awaiting market launch in Europe, has been recently approved by the European Commission.
Requiem provides control of sucking pests and extends quality of harvested produce. First registrations of Requiem are expected in some European countries before end of 2016. Market launch in Europe is planned for 2017.
“Requiem is the latest innovation from Bayer CropScience in the field of biological insecticides and an important addition to integrated pest management (IPM) programs in greenhouse vegetables,” said Gilles Chevallier, Global Product Management Biological Insecticides at Bayer CropScience. “Its mode of action is effective against sucking pests, especially thrips, whiteflies, aphids and mites, leading to healthier crops and better-quality produce.”
“We are very proud of the approval by the European Commission,” said Nick Wright, Global Regulatory Manager Biologicals at Bayer CropScience. “This is the first time a Bayer active substance gains approval under the new EU regulation 1107/2009.” The regulation was designed to ensure high level of protection of both human and animal health and the environment; while improving agricultural production. “The harmonization for the authorization of plant protection products within the EU will help us providing growers across Europe innovative tools like Requiem,” Wright added.
According to Bayer, Requiem was developed to control sucking pests in a wide range of fruits and vegetables, and some row crops. Requiem is intended for use as foliar insecticide and acaricide – in spray programs, as a standalone or together with chemical crop protection products. In addition to its efficacy level, the product offers growers flexible use-rates and flexible application timing. It is exempt from maximum residue levels (MRLs), IPM compatible, has a short re-entry interval, and no pre-harvest interval. Furthermore, it is a valuable tool for resistance management.
Bayer said Requiem is based on the optimized blend of terpenes intended to mimic the naturally occurring extract of the plant species Chenopodium ambrosioides near ambrosioides, a flowering plant commonly known as Epazote and American Wormseed. Bayer said it was able to get this blend successfully approved in the U.S. and the EU as a single active substance.